TARO Annual D&A
$31.09 M
-$1.03 M-3.22%
31 March 2024
Summary:
As of January 28, 2025, TARO annual depreciation & amortization is $31.09 million, with the most recent change of -$1.03 million (-3.22%) on March 31, 2024. During the last 3 years, it has risen by +$7.41 million (+31.31%).TARO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Quarterly D&A
$8.22 M
+$848.00 K+11.50%
31 March 2024
Summary:
As of January 28, 2025, TARO quarterly depreciation & amortization is $8.22 million, with the most recent change of +$848.00 thousand (+11.50%) on March 31, 2024. Over the past year, it has increased by +$848.00 thousand (+11.50%).TARO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO TTM D&A
$31.09 M
-$2.58 M-7.68%
31 March 2024
Summary:
As of January 28, 2025, TARO TTM depreciation & amortization is $31.09 million, with the most recent change of -$2.58 million (-7.68%) on March 31, 2024. Over the past year, it has dropped by -$2.58 million (-7.68%).TARO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.2% | +11.5% | -7.7% |
| 3 y3 years | +31.3% | +29.6% | +31.3% |
| 5 y5 years | +67.2% | +51.0% | +48.4% |
TARO Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -3.2% | -23.9% | -7.7% |
Taro Pharmaceutical Industries Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $31.09 M(-3.2%) | $8.22 M(+11.5%) | $31.09 M(-7.7%) |
| Dec 2023 | - | $7.37 M(-3.1%) | $33.68 M(+0.1%) |
| Sept 2023 | - | $7.61 M(-3.6%) | $33.63 M(+1.8%) |
| June 2023 | - | $7.89 M(-27.0%) | $33.04 M(+2.8%) |
| Mar 2023 | $32.13 M(+24.0%) | $10.81 M(+47.5%) | $32.13 M(+14.8%) |
| Dec 2022 | - | $7.33 M(+4.4%) | $27.99 M(+3.2%) |
| Sept 2022 | - | $7.02 M(+0.5%) | $27.11 M(+2.1%) |
| June 2022 | - | $6.98 M(+4.7%) | $26.55 M(+2.4%) |
| Mar 2022 | $25.91 M(+9.4%) | $6.67 M(+3.3%) | $25.91 M(+1.3%) |
| Dec 2021 | - | $6.45 M(+0.1%) | $25.59 M(+1.9%) |
| Sept 2021 | - | $6.45 M(+1.6%) | $25.11 M(+2.7%) |
| June 2021 | - | $6.35 M(+0.0%) | $24.45 M(+3.3%) |
| Mar 2021 | $23.68 M(+10.7%) | $6.34 M(+6.1%) | $23.68 M(+4.7%) |
| Dec 2020 | - | $5.98 M(+3.2%) | $22.62 M(+2.4%) |
| Sept 2020 | - | $5.79 M(+3.9%) | $22.09 M(+0.9%) |
| June 2020 | - | $5.57 M(+5.5%) | $21.88 M(+2.3%) |
| Mar 2020 | $21.38 M(+15.0%) | $5.28 M(-3.0%) | $21.38 M(+2.0%) |
| Dec 2019 | - | $5.45 M(-2.4%) | $20.96 M(+2.6%) |
| Sept 2019 | - | $5.58 M(+10.1%) | $20.44 M(+5.5%) |
| June 2019 | - | $5.07 M(+4.4%) | $19.37 M(+4.2%) |
| Mar 2019 | $18.60 M(+12.7%) | $4.86 M(-1.3%) | $18.60 M(+2.1%) |
| Dec 2018 | - | $4.92 M(+9.0%) | $18.21 M(+4.0%) |
| Sept 2018 | - | $4.52 M(+5.0%) | $17.52 M(+2.9%) |
| June 2018 | - | $4.30 M(-3.9%) | $17.02 M(+3.2%) |
| Mar 2018 | $16.50 M(+11.2%) | $4.47 M(+5.8%) | $16.50 M(+4.5%) |
| Dec 2017 | - | $4.23 M(+5.2%) | $15.78 M(+3.7%) |
| Sept 2017 | - | $4.02 M(+6.5%) | $15.23 M(+2.1%) |
| June 2017 | - | $3.77 M(+0.3%) | $14.91 M(+0.6%) |
| Mar 2017 | $14.83 M(-0.1%) | $3.76 M(+2.5%) | $14.83 M(+1.5%) |
| Dec 2016 | - | $3.67 M(-0.9%) | $14.61 M(+1.0%) |
| Sept 2016 | - | $3.71 M(+0.4%) | $14.46 M(-1.1%) |
| June 2016 | - | $3.69 M(+4.2%) | $14.63 M(-1.5%) |
| Mar 2016 | $14.85 M(-6.0%) | $3.54 M(+0.7%) | $14.85 M(-2.1%) |
| Dec 2015 | - | $3.52 M(-9.0%) | $15.17 M(-2.7%) |
| Sept 2015 | - | $3.87 M(-1.1%) | $15.60 M(-1.0%) |
| June 2015 | - | $3.91 M(+1.2%) | $15.75 M(-0.3%) |
| Mar 2015 | $15.80 M | $3.87 M(-2.1%) | $15.80 M(-1.8%) |
| Dec 2014 | - | $3.95 M(-1.9%) | $16.09 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $4.02 M(+1.5%) | $16.21 M(-0.5%) |
| June 2014 | - | $3.96 M(-4.7%) | $16.30 M(-1.6%) |
| Mar 2014 | $16.57 M(-6.7%) | $4.16 M(+2.3%) | $16.57 M(-0.7%) |
| Dec 2013 | - | $4.07 M(-1.0%) | $16.68 M(-2.3%) |
| Sept 2013 | - | $4.11 M(-3.0%) | $17.07 M(-2.2%) |
| June 2013 | - | $4.23 M(-0.9%) | $17.46 M(-1.7%) |
| Mar 2013 | $17.77 M(+286.4%) | $4.27 M(-4.1%) | $17.77 M(+31.7%) |
| Dec 2012 | - | $4.46 M(-0.9%) | $13.49 M(-0.8%) |
| Sept 2012 | - | $4.50 M(-1.0%) | $13.60 M(-1.5%) |
| June 2012 | - | $4.54 M(-0.4%) | $13.81 M(-26.3%) |
| Mar 2012 | $4.60 M(-75.5%) | - | - |
| Dec 2011 | $18.73 M(-0.5%) | $4.56 M(-3.1%) | $18.73 M(-1.4%) |
| Sept 2011 | - | $4.71 M(-1.0%) | $18.99 M(+0.0%) |
| June 2011 | - | $4.75 M(+1.0%) | $18.99 M(+0.2%) |
| Mar 2011 | - | $4.71 M(-2.4%) | $18.95 M(+0.6%) |
| Dec 2010 | $18.83 M(+2.1%) | $4.82 M(+2.5%) | $18.83 M(+34.4%) |
| Sept 2010 | - | $4.71 M(-0.1%) | $14.00 M(+50.6%) |
| June 2010 | - | $4.71 M(+2.7%) | $9.30 M(+102.7%) |
| Mar 2010 | - | $4.59 M | $4.59 M |
| Dec 2009 | $18.45 M(-12.9%) | - | - |
| Dec 2008 | $21.19 M(-6.3%) | - | - |
| Dec 2007 | $22.61 M(-9.9%) | - | - |
| Dec 2006 | $25.11 M(+4.6%) | - | - |
| Dec 2005 | $24.01 M(+22.4%) | - | - |
| Dec 2004 | $19.62 M(+36.1%) | - | - |
| Dec 2003 | $14.41 M(+71.6%) | - | - |
| Dec 2002 | $8.40 M(+24.3%) | - | - |
| Dec 2001 | $6.76 M(+12.8%) | - | - |
| Dec 2000 | $5.99 M(+35.8%) | - | - |
| Dec 1999 | $4.41 M(+7.6%) | - | - |
| Dec 1998 | $4.10 M(+24.2%) | - | - |
| Dec 1997 | $3.30 M(+37.5%) | - | - |
| Dec 1996 | $2.40 M(+33.3%) | - | - |
| Dec 1995 | $1.80 M(+28.6%) | - | - |
| Dec 1994 | $1.40 M(+40.0%) | - | - |
| Dec 1993 | $1.00 M(+42.9%) | - | - |
| Dec 1992 | $700.00 K(+40.0%) | - | - |
| Dec 1991 | $500.00 K | - | - |
FAQ
- What is Taro Pharmaceutical Industries annual depreciation & amortization?
- What is the all time high annual D&A for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual D&A year-on-year change?
- What is Taro Pharmaceutical Industries quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly D&A year-on-year change?
- What is Taro Pharmaceutical Industries TTM depreciation & amortization?
- What is the all time high TTM D&A for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries TTM D&A year-on-year change?
What is Taro Pharmaceutical Industries annual depreciation & amortization?
The current annual D&A of TARO is $31.09 M
What is the all time high annual D&A for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual depreciation & amortization is $32.13 M
What is Taro Pharmaceutical Industries annual D&A year-on-year change?
Over the past year, TARO annual depreciation & amortization has changed by -$1.03 M (-3.22%)
What is Taro Pharmaceutical Industries quarterly depreciation & amortization?
The current quarterly D&A of TARO is $8.22 M
What is the all time high quarterly D&A for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly depreciation & amortization is $10.81 M
What is Taro Pharmaceutical Industries quarterly D&A year-on-year change?
Over the past year, TARO quarterly depreciation & amortization has changed by +$848.00 K (+11.50%)
What is Taro Pharmaceutical Industries TTM depreciation & amortization?
The current TTM D&A of TARO is $31.09 M
What is the all time high TTM D&A for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high TTM depreciation & amortization is $33.68 M
What is Taro Pharmaceutical Industries TTM D&A year-on-year change?
Over the past year, TARO TTM depreciation & amortization has changed by -$2.58 M (-7.68%)